News Quantified

IRMD – iradimed corporation (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

iRadimed (NASDAQ:IRMD) had its "buy (b-)" rating reaffirmed by analysts at Weiss Ratings.

What Makes IRADIMED CORPORATION (IRMD) a Compelling Opportunity? [Yahoo! Finance]

iRadimed (NASDAQ:IRMD) had its "buy (b-)" rating reaffirmed by analysts at Weiss Ratings.

IRADIMED Announces Special Cash Dividend of $0.50 Per Share

iRadimed (NASDAQ:IRMD) had its "buy (b-)" rating reaffirmed by analysts at Weiss Ratings.

8.7%

BEAT

13.4%

BEAT

-1.8%

BEAT

-0.4%

BEAT

Lake Street Capital

Form 4 IRADIMED CORP For: Dec 22 Filed by: Susi Roger E.

Form 4 IRADIMED CORP For: Dec 15 Filed by: Susi Roger E.

Form 4 IRADIMED CORP For: Dec 11 Filed by: ALLEN MONTY K

Form 4 IRADIMED CORP For: Dec 11 Filed by: Scharen-Guivel Hilda Frederique

Form 4 IRADIMED CORP For: Dec 11 Filed by: HAWKINS JAMES B

Top News Gainers

7/29 Form 8-K IRADIMED CORP For: Jul 29 33.3%

9/12 Form 4 IRADIMED CORP For: Sep 10 Filed by: JOHNSON BRENT 13.4%

3/24 Iradimed Corp (NASDAQ: IRMD) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $18.00 price target on the stock. 12.5%

3/31 Iradimed Corp (NASDAQ: IRMD) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $21.00 price target on the stock. 9.7%

12/11 Form 4 IRADIMED CORP For: Dec 09 Filed by: JOHNSON BRENT 7.7%

2/6 IRADIMED CORPORATION Announces Fourth Quarter 2019 Financial Results 7.1%

4/3 Iradimed Corp (NASDAQ: IRMD) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 6.9%

10/30 Q3/2019 9/30/2019 EPS 0.230 ZacksConsensus 0.130 ActVsEst 0.100 - Beat 5.7%

4/14 Iradimed Corp (NASDAQ: IRMD) had its price target lowered by analysts at Roth Capital from $32.00 to $30.00. 5.0%

8/7 Form 4 IRADIMED CORP For: Aug 05 Filed by: JOHNSON BRENT 4.9%

Top News Decliners

4/30 Form 8-K IRADIMED CORP For: Apr 30 -9.0%

3/12 IRADIMED CORPORATION Announces the Appointment of Lynn Neuhardt as Vice President of Research and Development -7.8%

5/7 Iradimed Corp (NASDAQ: IRMD) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $28.00 price target on the stock. -6.1%

11/1 Iradimed Corp (NASDAQ: IRMD) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -5.8%

2/25 Form 4 IRADIMED CORP For: Feb 24 Filed by: JOHNSON BRENT -5.6%

2/28 Iradimed Corp (NASDAQ: IRMD) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -5.1%

8/5 Form 4 IRADIMED CORP For: Aug 01 Filed by: Waldman Louis S. -5.1%

11/5 Form 4 IRADIMED CORP For: Nov 04 Filed by: Nardi Steven M. -4.9%

3/26 Form 4 IRADIMED CORP For: Mar 24 Filed by: JOHNSON BRENT -4.5%

3/4 Form 4 IRADIMED CORP For: Mar 02 Filed by: JOHNSON BRENT -3.9%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day